secwatch.observer — SEC 8-K summary
======================================

Issuer:     CARDINAL HEALTH INC (CAH)
CIK:        0000721371
Form:       8-K
Filed at:   2025-01-30T23:59:59+00:00
Accession:  0000721371-25-000009
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cardinal Health Q2 non-GAAP EPS $1.93 (+2% YoY); guides FY25 $7.85-8.00, closes GI Alliance deal
--------------------------------------------------------------------------------

- Revenue $55.3B (-4% YoY; +16% ex-large customer expiration); GAAP EPS $1.65, non-GAAP EPS $1.93.
- Pharm & Specialty segment profit $531M (+7%); Global Medical Products profit $18M vs $11M.
- FY2025 non-GAAP EPS guidance raised to $7.85-$8.00 from $7.75-$7.90; segment profit growth revised.
- Completed acquisition of 73% of GI Alliance (gastroenterology MSO) and ION acquisition in Dec.
- Started commercial-scale production of actinium-225 for theranostics; new distribution center underway.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/721371/000072137125000009/0000721371-25-000009-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/721371/000072137125000009/cah-20250130.htm
  HTML page:      https://secwatch.observer/filing/0000721371-25-000009

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer